SHMT2 and cancer: The reversible interconversion of serine and glycine is catalyzed by, either the cytosolic or mitochondrial serine hydroxymethyltransferase (SHMT), SHMT1 or SHMT2, respectively, of which the latter is most prominently expressed in cancer [12–15].